ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study

被引：0

作者：

Owonikoko, T. ^{[1
]}

Burns, T. F. ^{[2
]}

Chiappori, A. A. ^{[3
]}

Drapkin, B. ^{[4
]}

Gentzler, R. D. ^{[5
]}

Goldschmidt, J. ^{[6
]}

Hakimian, D. ^{[7
]}

Jotte, R. ^{[8
]}

Liu, S. V. ^{[9
]}

Onitilo, A. A. ^{[10
]}

Pennell, N. A. ^{[11
]}

Potugari, B. ^{[12
]}

Rios, J. ^{[13
]}

Sands, J. ^{[14
]}

Spira, A. ^{[15
]}

Wang, B. ^{[16
]}

Waterhouse, D. M. ^{[17
]}

Lowenthal, B. ^{[18
]}

Bebchuk, J. ^{[18
]}

Eli, L. D. ^{[18
]}

Wong, E. K. ^{[18
]}

Dowlati, A. ^{[19
]}

机构：

[1] Univ Maryland, Baltimore, MD USA

[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Univ Texas SouthWestern Med Ctr, Dallas, TX USA

[5] Univ Virginia, Charlottesville, VA USA

[6] US Oncol, Blue Ridge Canc Ctr, Blacksburg, VA USA

[7] US Oncol, Illinois Canc Specialists, Niles, IL USA

[8] Rocky Mt Canc Ctr, Lone Tree, CO USA

[9] Georgetown Univ, Washington, DC USA

[10] Marshfield Clin Wisconsin, Rapids, WI USA

[11] Cleveland Clin, Cleveland, OH USA

[12] Henry Ford Hosp, Detroit, MI USA

[13] Sarah Cannon Zangmeister Canc Ctr Columbus, Columbus, OH USA

[14] Dana Faber Canc Inst, Boston, MA USA

[15] Virginia Canc Specialists Res Inst, Fairfax, VA USA

[16] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA

[17] OHC Oncol Hematol Care, Cincinnati, OH USA

[18] Puma Biotechnol, Los Angeles, CA USA

[19] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

Alisertib; Small-cell lung cancer; Aurora kinase A inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.13A.13

引用

页码：S212 / S213

页数：2

共 50 条

[21] Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Luo, Jing
Xu, Liming
Zhao, Lujun
Cao, Yuanjie
Pang, Qingsong
Wang, Jun
Yuan, Zhiyong
Wang, Ping
RADIATION ONCOLOGY, 2017, 12
[22] Prognostic significance of novel inflammatory markers in extensive-stage small-cell lung cancer
Yilmaz, Hatice
Yersal, Ozlem
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (03) : 691 - 696
[23] Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer
Riano, Ivy
Patel, Shruti R.
Liu, Stephen V.
Duma, Narjust
CLINICS AND PRACTICE, 2021, 11 (03) : 441 - 454
[24] Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib
Chen, Dongfang
Xu, Jianlin
Zhao, Yizhuo
Chu, Tianqing
Zhong, Hua
Han, Baohui
Zhong, Runbo
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (02) : 401 - 406
[25] Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Jing Luo
Liming Xu
Lujun Zhao
Yuanjie Cao
Qingsong Pang
Jun Wang
Zhiyong Yuan
Ping Wang
Radiation Oncology, 12
[26] Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer
Cheng, Ying
Liu, Xiao-Qing
Fan, Yun
Liu, Yun-Peng
Liu, Yi
Liu, Ying
Ma, Li-Xia
Liu, Xian-Hong
Li, Hui
Bao, Hui-Zheng
Liu, Jing-Jing
Zhang, Shuang
Wu, Chun-Jiao
FUTURE ONCOLOGY, 2016, 12 (06) : 789 - 799
[27] Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib
Dongfang Chen
Jianlin Xu
Yizhuo Zhao
Tianqing Chu
Hua Zhong
Baohui Han
Runbo Zhong
Journal of Cancer Research and Clinical Oncology, 2020, 146 : 401 - 406
[28] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
Horn, Leora
Zhao, Zhiguo
Sandler, Alan
Johnson, David
Shyr, Yu
Wolff, Steven
DeVore, Russell F.
Laskin, Janessa
CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165
[29] Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer
Konala, Venu Madhav
Madhira, Bhaskar Reddy
Ashraf, Sara
Graziano, Stephen
ONCOLOGY, 2020, 98 (11) : 749 - 754
[30] A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer
Kalemkerian, GP
Ali, MA
Luthra, K
Wozniak, AJ
Valdivieso, M
Kraut, MJ
CANCER INVESTIGATION, 2001, 19 (03) : 234 - 238

← 1 2 3 4 5 →